Medical Device News Magazine

Nanovis Announces Alpha Launch of the 1st & Only Bioceramic Nanotube-Enhanced Pedicle Screw System, Nano FortiFix®

First use of a nanotechnology enhanced pedicle screw with label claims to increase and accelerate human osteoblast and mesenchymal stem cell calcified extracellular matrix production in vitro

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Nanovis, an award-winning technology company with unique and differentiated nanotechnology surfaces for improving bone growth and fighting infection, is pleased to announce the first implantations of its Bioceramic Nanotube-Enhanced pedicle screw system, Nano FortiFix, the only nanotechnology designated titanium-surfaced pedicle screw.

Nano FortiFix pedicle screws are designed with a proprietary and patent protected bio-ceramic nanotube surface. Unlike other technologies, Nanovis’s bioceramic nanotubes were granted a nanotechnology designation with specific label language stating “The nanotube arrays have been shown to increase and accelerate calcified extracellular matrix production in vitro”. The Nano FortiFix label also includes statistically significantly superior human osteoblast and mesenchymal stem cell calcified extracellular matrix production data compared to other surfaces.

“This nanotechnology label and accompanying comparative data provides unusual clarity for surgeons and hospital contracting executives when selecting a technology that is unequivocally differentiated for their patients seeking the best care,” says Matt Hedrick, Nanovis CEO.

Nanovis was the first company to receive nanotechnology designation for PEEK enhanced titanium interbodies and is the first and only company to receive nanotechnology designation for titanium-surfaced pedicle screws.

“I’m pleased to now have a pedicle screw system with cutting edge nanotechnology to offer my patients. I’ve been using Nano FortiFix pedicle screws in combination with Nano FortiCore interbodies, giving my patients a  fusion using 360˚ nanotechnology. It’s exciting that nanotechnology is no longer limited to the interbody space,” says Alan McGee MD of Parkview Health in Fort Wayne, IN.

“Nanovis is pleased with the success of this alpha launch. The feedback from innovative and discerning surgeons and distributors has been positive, encouraging, and primes us for the full commercial launch of our open and MIS systems,” says Jeff Shepherd, Nanovis Vice President of Sales.

This is Nanovis’ 5th implant system cleared with a bioceramic nanotube surface establishing a well understood regulatory pathway. Nanovis’ commitment to help reduce the pain and suffering from implant loosening has never been higher and we are grateful to the surgeons, scientists, and employees that have created such a powerful combination of technology-enhanced systems.

Nanovis is actively expanding distribution for bioceramic nanotube enhanced Nano FortiCore interbodies and Nano FortiFix pedicle screws.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”